None listed
Conditions
Brief summary
The primary aim of this randomised controlled trial (RCT) is to compare the clinical and cost eff ectiveness of new Vascular Access Specialist model with the Generalist inserter model (inserted by a doctor or nurse in emergency department). You may be eligible to participate in this trial if you are an emergency department patient more than theage of 18 and are requiring a peripheral venous catheter inserted as part of your therapy. All participants enrolled in this trial will be randomly allocated (by chance) to receive one of two options (inserted by either a Vascular Access Specialist or a doctor/nurse in emergency department). Participants and families will be asked to rate the satisfaction of the insertion, and the peripheral intravenous catheter will be observed closely to examine side effects. It is hoped that the findings of this trial will provide information on which insertion model is the most effective in preventing first insertion failure.
Interventions
Participants in this study are patients who require intravenous catheters (IVC) in emergency departments (ED). Consenting participants will receive a IVC inserted by a Vascular Access Specialist (nurses trained in ultrasound-guided IVC insertion) in the intervention group when a PIVC is required in ED. The IVC will remain in situ as long as it is required as per hospital policy. The insertion length of the IVC vary depending on the complexity of patient's venous condition and device is required.
Participants in this study are patients who require intravenous catheters (IVC) in emergency departments (ED). Consenting participants will receive a IVC inserted by a Vascular Access Specialist (nurses trained in ultrasound-guided IVC insertion) in the intervention group when a PIVC is required in ED. The IVC will remain in situ as long as it is required as per hospital policy. The insertion length of the IVC vary depending on the complexity of patient's venous condition and device is required. Patients will be monitored daily by a research nurse.
Sponsors
Royal Brisbane and Women's Hospital
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
• 18 years and over • likely being admitted into the hospital and requiring peripherally-compatible IV therapy for greater than or equal to 24 hours • Informed written consent
Exclusion criteria
• Non-English-speaking patients without an interpreter • Patients requiring urgent care (e.g. triage category one) • Patient receiving end-of-life care • Previous enrolment in the study
Outcome results
None listed